Related Experiment Video
Updated: Jul 9, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Advances in specific immunotherapy for prostate cancer.
Andrea Kiessling1, Susanne Füssel, Rebekka Wehner
1Institute of Immunology, Medical Faculty, Technical University of Dresden, Dresden, Germany.
European Urology
|December 7, 2007
Summary
Specific immunotherapy, using T cells and antibodies, shows promise for treating advanced prostate cancer. Further research combining these strategies with other therapies may improve outcomes.
Area of Science:
- Immunology
- Oncology
- Cancer Therapy
Background:
- Advanced prostate cancer lacks effective treatments, driving the search for novel therapeutic approaches.
- Immunotherapy offers a promising avenue for targeting prostate cancer through the immune system.
Purpose of the Study:
- To review specific immunotherapeutic strategies for prostate cancer.
- To explore T-cell and antibody-based approaches for prostate cancer treatment.
Main Methods:
- Literature review of studies on tumor antigens and immunotherapy design.
- PubMed database search using keywords: antibodies, clinical trials, dendritic cells, immunotherapy, prostate cancer, T cells.
Main Results:
- T cells (CTLs, CD4+ T cells) and antibodies are key components of antitumor immunity.
- Immunotherapy strategies using tumor antigens, dendritic cells, and monoclonal antibodies are safe and feasible.
- Clinical trials demonstrate the induction of immunologic and clinical responses in prostate cancer patients.
Conclusions:
- Specific immunotherapy is a promising treatment for prostate cancer.
- Combining T-cell and antibody-based strategies with radio-, hormone-, chemo-, or antiangiogenic therapy may enhance efficacy.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...